Floatz logo

VOLITINIB

Advanced Gastric Adenocarcinoma

Samsung Medical CenterSmall moleculePhase 1/2Dormant
CCC
50/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
37/ 100
Competitive Position
89/ 100

Competitive context

65 Active assets in the Advanced Gastric Adenocarcinoma cohort.

Asset / SponsorPhaseRating
FLUOROURACILUM
Boehringer Ingelheim
Phase 3BB
Capecitabine
Shanghai Zhongshan Hospital
Phase 3BB
TRASTUZUMAB
Boehringer Ingelheim
Phase 2BB
CIS-DIAMMINEDICHLOROPLATINUM II
Mayo Clinic
Phase 3BB
Eloxatin
Shanghai Zhongshan Hospital
Phase 3BB

View all 50 →

Same molecule, other indications

VOLITINIB is also rated in:

papillary renal cell carcinomaDormant
BB
Indicative ·
66 / 100
View asset →
non-small cell lung carcinomaDormant
BB
Indicative ·
64 / 100
View asset →
renal cell carcinomaDormant
BB
Indicative ·
64 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →